Kevin Sweeney

2.4k total citations
58 papers, 1.7k citations indexed

About

Kevin Sweeney is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Kevin Sweeney has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 13 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Kevin Sweeney's work include Antibiotics Pharmacokinetics and Efficacy (18 papers), Antibiotic Resistance in Bacteria (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Kevin Sweeney is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (18 papers), Antibiotic Resistance in Bacteria (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Kevin Sweeney collaborates with scholars based in United States, United Kingdom and New Zealand. Kevin Sweeney's co-authors include Diane R. Mould, Richard Quintiliani, C H Nightingale, Wonkyung Byon, Dennis J. Chapron, Irving H. Gomolin, F. William Sunderman, Carol Cronenberger, David R. Plowchalk and Allan H. Marcus and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Kevin Sweeney

58 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Sweeney United States	21	295	294	268	225	215	58	1.7k
Xingang Li China	20	253 0.9×	259 0.9×	120 0.4×	152 0.7×	155 0.7×	116	1.4k
Hülya Yılmaz Türkiye	24	124 0.4×	489 1.7×	188 0.7×	137 0.6×	269 1.3×	134	1.8k
Nitin Mehrotra United States	22	166 0.6×	360 1.2×	113 0.4×	395 1.8×	49 0.2×	59	1.8k
Tim Mant United Kingdom	23	158 0.5×	384 1.3×	75 0.3×	141 0.6×	349 1.6×	55	2.2k
Marie E. Steiner United States	27	137 0.5×	330 1.1×	189 0.7×	120 0.5×	737 3.4×	122	2.9k
Deborah Rund Israel	27	107 0.4×	597 2.0×	127 0.5×	265 1.2×	170 0.8×	89	2.8k
Joannes J.M. Marx Netherlands	32	64 0.2×	445 1.5×	114 0.4×	112 0.5×	209 1.0×	96	3.2k
Soo‐Taek Uh South Korea	29	328 1.1×	642 2.2×	130 0.5×	217 1.0×	296 1.4×	152	3.2k
Sudarshan Ramachandran United Kingdom	24	232 0.8×	969 3.3×	134 0.5×	198 0.9×	198 0.9×	105	2.1k
Erkki Elonen Finland	36	191 0.6×	849 2.9×	415 1.5×	1.1k 4.8×	115 0.5×	117	4.0k

Countries citing papers authored by Kevin Sweeney

Since Specialization

Citations

This map shows the geographic impact of Kevin Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Sweeney more than expected).

Fields of papers citing papers by Kevin Sweeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Sweeney. The network helps show where Kevin Sweeney may publish in the future.

Co-authorship network of co-authors of Kevin Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Sweeney. A scholar is included among the top collaborators of Kevin Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Sweeney. Kevin Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsamandouras, Nikolaos, et al.. (2024). Employing zero-inflated beta distribution in an exposure-response analysis of TYK2/JAK1 inhibitor brepocitinib in patients with plaque psoriasis. Journal of Pharmacokinetics and Pharmacodynamics. 51(3). 265–277. 2 indexed citations

Plowchalk, David R., et al.. (2023). Population PK/PD modeling of low‐density lipoprotein cholesterol response in hypercholesterolemic participants following administration of bococizumab, a potent anti‐PCSK9 monoclonal antibody. CPT Pharmacometrics & Systems Pharmacology. 12(12). 2013–2026. 5 indexed citations

Sweeney, Kevin, et al.. (2019). Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin®) in patients with advanced non-squamous non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 85(3). 487–499. 7 indexed citations

Sweeney, Kevin, et al.. (2017). Microbiology Alloplastic Total Joint Infections: A 20-Year Retrospective Study. Journal of Oral and Maxillofacial Surgery. 76(2). 288–293. 7 indexed citations

Li, Rui, Tristan S. Maurer, Kevin Sweeney, & Hugh A. Barton. (2016). Does the Systemic Plasma Profile Inform the Liver Profile? Analysis Using a Physiologically Based Pharmacokinetic Model and Individual Compounds. The AAPS Journal. 18(3). 746–756. 10 indexed citations

Ballantyne, Christie M., Joel Neutel, William Duggan, et al.. (2014). =EFFICACY AND SAFETY OF BOCOCIZUMAB (RN316/PF-04950615), A MONOCLONAL ANTIBODY AGAINST PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 IN STATIN-TREATED HYPERCHOLESTEROLEMIC SUBJECTS: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY (NCT: 01592240). Journal of the American College of Cardiology. 63(12). A1374–A1374. 16 indexed citations

Sahasrabudhe, Vaishali, Kevin Sweeney, Meera Tugnait, et al.. (2011). The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism. Journal of Translational Medicine. 9(1). 180–180. 48 indexed citations

Malhotra, Bimal, Paul Glue, Kevin Sweeney, et al.. (2007). Thorough QT Study with Recommended and Supratherapeutic Doses of Tolterodine. Clinical Pharmacology & Therapeutics. 81(3). 377–385. 64 indexed citations

Eckhardt, S. Gail, Jinee Rizzo, Kevin Sweeney, et al.. (1999). Phase I and Pharmacologic Study of the Tyrosine Kinase Inhibitor SU101 in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 17(4). 1095–1095. 55 indexed citations

10.

Godfrey, Christopher, et al.. (1998). The population pharmacokinetics of long‐term methotrexate in rheumatoid arthritis. British Journal of Clinical Pharmacology. 46(4). 369–376. 68 indexed citations

11.

Nightingale, C H, et al.. (1995). Comparison of the Pharmacodynamic Activity of Cefotaxime plus Metronidazole With Cefoxitin and Ampicillin plus Sulbactam. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(4). 479–486. 4 indexed citations

12.

Taft, David R. & Kevin Sweeney. (1995). The influence of protein binding on the elimination of acetazolamide by the isolated perfused rat kidney: evidence of albumin-mediated tubular secretion.. Journal of Pharmacology and Experimental Therapeutics. 274(2). 752–760. 11 indexed citations

13.

Herbette, Leo G., Pamela E. Mason, Kevin Sweeney, Mark W. Trumbore, & Ronald P. Mason. (1994). Favorable amphiphilicity of nimodipine facilitates Its interactions with brain membranes. Neuropharmacology. 33(2). 241–249. 20 indexed citations

14.

Nightingale, Charles H., et al.. (1993). Comparison of the Pharmacokinetic and Pharmacodynamic Activity of Piperacillin and Mezlocillin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(6). 607–612. 4 indexed citations

15.

Nightingale, Charles H., et al.. (1992). Lomefloxacin concentrations in bone after a single oral dose. The American Journal of Medicine. 92(4). S15–S17. 3 indexed citations

16.

Nightingale, C H, et al.. (1992). The Relative Bioavailability of Temafloxacin Administered through a Nasogastric Tube With and Without Enteral Feeding. Clinical Pharmacokinetics. 22(Supplement 1). 43–47. 9 indexed citations

17.

Amerasinghe, F. P., Nancy L. Breisch, Abdu F. Azad, et al.. (1992). Distribution, Density, and Lyme Disease Spirochete Infection in Ixodes dammini (Acari: Ixodidae) on White-Tailed Deer in Maryland. Journal of Medical Entomology. 29(1). 54–61. 35 indexed citations

18.

Nightingale, Charles H., et al.. (1991). Quantification of in-vitro post-antibiotic effect based on the mean recovery-time. II: A comparison of colony counting versus photometric methods for the determination of bacterial growth. Journal of Antimicrobial Chemotherapy. 28(4). 515–521. 5 indexed citations

19.

Nightingale, Charles H., et al.. (1990). Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutrition. Diagnostic Microbiology and Infectious Disease. 13(2). 99–102. 18 indexed citations

20.

Yuk, Jong Min, C H Nightingale, Kevin Sweeney, Robert E. Levitz, & Richard Quintiliani. (1988). Pharmokinetics of Nafcillin in Obesity. The Journal of Infectious Diseases. 157(5). 1088–1089. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact